Close Menu
  • Home
  • Life Insurance
  • Auto Insurance
  • Home Insurance
  • Health Insurance
  • Business Insurance
  • Travel Insurance
  • Specialized Insurance
  • Insurance Tips & Guides
Facebook X (Twitter) Instagram
Insure GenZInsure GenZ Sunday, February 8
  • About Us
  • Contact Us
  • Disclaimer
  • Terms & Conditions
  • Privacy Policy
Facebook X (Twitter) Instagram
Subscribe
  • Home
  • Life Insurance
  • Auto Insurance
  • Home Insurance
  • Health Insurance
  • Business Insurance
  • Travel Insurance
  • Specialized Insurance
  • Insurance Tips & Guides
Insure GenZInsure GenZ
Home»Insurance Tips & Guides»UK Warns of Pancreatitis, Deaths Tied to Obesity Drugs Wegovy, Mounjaro
Insurance Tips & Guides

UK Warns of Pancreatitis, Deaths Tied to Obesity Drugs Wegovy, Mounjaro

AwaisBy AwaisJanuary 30, 2026No Comments2 Mins Read0 Views
Facebook Twitter Pinterest Telegram LinkedIn Tumblr Copy Link Email
Follow Us
Google News Flipboard
UK Warns of Pancreatitis, Deaths Tied to Obesity Drugs Wegovy, Mounjaro
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link

The UK warned some patients have died of severe inflammation of the pancreas linked to obesity and diabetes drugs such as Eli Lilly & Co.’s Mounjaro and Novo Nordisk A/S’s Wegovy.

Though the worst cases of pancreatitis were rare, the UK Medicines and Healthcare products Regulatory Agency said Thursday doctors and patients should know some incidents had been particularly severe, as it strengthened its warning over taking the drugs.

The guidance applies to medicines that mimic the GLP-1 gut hormone, like Wegovy, as well as drugs that imitate a second hormone called GIP. Mounjaro falls in this category. Both already carry similar warnings in the US.

Novo said patients should only take these medications when under the supervision of a health professional who can advise them on side effects, and that the benefit-risk profile of GLP-1 medicines remains positive.

Lilly said an inflamed pancreas may affect as many as 1 in 100 people and advised patients to talk to their doctors before using Mounjaro if they’ve ever had pancreatitis. The drugmaker said it takes reports regarding patient safety seriously and will work with prescribers to ensure they have appropriate safety information.

The UK agency received almost 1,300 reports of the condition associated with the drugs from 2007 to October 2025. They include 19 deaths and 24 cases of necrotizing pancreatitis, in which tissue in the pancreas dies. About 25 million packs of the drugs have been dispensed in the UK in the past five years.

The agency advised people taking the obesity drugs to seek a doctor if they experience severe and persistent abdominal pain that may radiate to the back, potentially alongside nausea and vomiting.

It also advised doctors to ask patients with such symptoms whether they’d been taking the drugs, given the risk that if they were bought privately they might not appear on a patient’s medical history held by the National Health Service.

Photograph: Wegovy injection pens; photo credit: Shelby Knowles/Bloomberg

Copyright 2026 Bloomberg.

Was this article valuable?


Here are more articles you may enjoy.

Interested in Drugs?

Get automatic alerts for this topic.

Deaths Drugs Mounjaro Obesity Pancreatitis Tied Warns Wegovy
Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Telegram Email Copy Link
Awais
  • Website

Related Posts

Starbucks Wins Dismissal of Missouri Lawsuit Over DEI Policies

February 6, 2026

WTW Reports Q4 Organic Revenue Growth of 6%; Data Center Clients Boost Business

February 6, 2026

Leading South Korean Insurers Explore India Entry, Sources Say

February 6, 2026
Leave A Reply Cancel Reply

Our Latest Blogs

Only 30% of insurer AI projects make it past pilot stage, report finds

February 8, 2026

Allstate outpaces Progressive as it doubles Q4 net income to $3.8 billion

February 8, 2026

Italy foils cyberattacks on foreign ministry and Cortina Olympics sites

February 8, 2026

US commercial renewal rates stay high but show signs of easing

February 7, 2026
Recent Posts
  • Only 30% of insurer AI projects make it past pilot stage, report finds
  • Allstate outpaces Progressive as it doubles Q4 net income to $3.8 billion
  • Italy foils cyberattacks on foreign ministry and Cortina Olympics sites
  • US commercial renewal rates stay high but show signs of easing
  • Howden Group completes issuance of $690 million add-on senior notes

Subscribe to Updates

Insure Genz is a modern insurance blog built for the next generation. Subscribe it for more updates.

Insure Genz is a modern insurance blog built for the next generation. We break down complex topics across categories like Auto, Health, Business, Life, and Travel Insurance — making them simple, useful, and easy to understand. Whether you're just getting started or looking for expert tips and guides, we've got you covered with clear, reliable content.

Our Picks

Only 30% of insurer AI projects make it past pilot stage, report finds

February 8, 2026

Allstate outpaces Progressive as it doubles Q4 net income to $3.8 billion

February 8, 2026

Italy foils cyberattacks on foreign ministry and Cortina Olympics sites

February 8, 2026

US commercial renewal rates stay high but show signs of easing

February 7, 2026
Most Popular

Only 30% of insurer AI projects make it past pilot stage, report finds

February 8, 2026

Allstate outpaces Progressive as it doubles Q4 net income to $3.8 billion

February 8, 2026

Italy foils cyberattacks on foreign ministry and Cortina Olympics sites

February 8, 2026

US commercial renewal rates stay high but show signs of easing

February 7, 2026
  • About Us
  • Contact Us
  • Disclaimer
  • Terms & Conditions
  • Privacy Policy
© 2026 Insure GenZ. Designed by Insure GenZ.

Type above and press Enter to search. Press Esc to cancel.